Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading update

28 Mar 2024 07:00

RNS Number : 5857I
IDOX PLC
28 March 2024
Β 

28 March 2024

Idox plc

('Idox'Β orΒ theΒ 'Group'Β orΒ theΒ 'Company')

AGM Trading update

Good momentum continues in the current financial year

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset-intensive sectors, is pleased to issue a trading update for the period from 1 November 2023 to date, ahead of today's Annual General Meeting.

Highlights during the period include:

Β· Operational and financial performance continue to be in line with the Board's expectations and we remain confident about the outlook for the year.

Β· High levels of recurring revenue, contract renewals, orderbook and pipeline provide good visibility, leaving Idox well placed to grow by double digits in FY24.

Β· With a strong foundation in property and asset-based solutions and data services we continue to enhance and grow our capabilities across the Group.

Β· The integration of Emapsite (acquired August 2023) is progressing well and in line with our expectations.

Β· Idox has an attractive M&A pipeline with significant financial resources for larger, accretive and enhancing acquisitions at appropriate valuations.

A further trading update will be issued following the half year ending 30 April 2024.

David Meaden, Chief Executive Officer, said:

"We remain confident that Idox is well positioned for growth in FY24 and beyond. The Group has made a good start to the year and continues to trade in line with the Board's expectations. Our focus on securing high quality recurring revenue and repeatable services provides confidence in delivering double digit growth in FY24. We have a healthy balance sheet and are confident we can maximise the opportunities for profitable organic and inorganic growth whilst remaining resilient to the current macro-economic challenges."

For further information please contact:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com

David Meaden, Chief Executive

Β 

Anoop Kang, Chief Financial Officer

Β 

Β 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Paul Gillam

Β 

Adam Telling

Β 

Β 

MHP

+ 44 (0) 20 3128 8100

Reg Hoare

Β idox@mhpgroup.com

Ollie Hoare

Matthew Taylor

Β 

About Idox plc

For more information seeΒ www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRGDXRDDDGSR
Date   Source Headline
21st Feb 20227:00 amRNSDirectorate Change
11th Feb 20228:46 amRNSGrant of Options
27th Jan 20227:40 amRNSProgressive publishes new research
27th Jan 20227:00 amRNSFinal Results
12th Jan 20227:00 amRNSNotice of Final Results
9th Dec 20219:50 amRNSIdox hosts company event focused on sustainability
25th Nov 20217:00 amRNSExercise of Share Options & Total Voting Rights
16th Nov 20217:00 amRNSYear End Trading Update
7th Oct 20218:08 amRNSHolding(s) in Company
5th Oct 20217:00 amRNSAcquisition
1st Oct 202111:25 amRNSExercise of Share Options & Total Voting Rights
9th Aug 20217:00 amRNSAcquisition
23rd Jul 20212:01 pmRNSHolding(s) in Company
19th Jul 20211:47 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSExercise of Share Options & Total Voting Rights
15th Jun 20217:00 amRNSHalf-year Report
7th Jun 20217:00 amRNSAcquisition
2nd Jun 20217:00 amRNSExercise of Share Options & Total Voting Rights
24th May 202111:40 amRNSInvestor presentation
20th May 20217:00 amRNSFY21 H1 Trading Update
23rd Apr 20214:00 pmRNSExercise of Share Options & Total Voting Rights
15th Apr 20211:41 pmRNSGrant of Options
13th Apr 20217:00 amRNSExercise of Share Options & Total Voting Rights
12th Apr 20219:40 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSFY21 Q1 Trading Update
22nd Mar 20212:46 pmRNSForm 8.3 - IDOX PLC
19th Mar 20219:07 amRNSForm 8.5 (EPT/RI) IDOX Plc
19th Mar 20217:01 amRNSDisposal of Idox Grants Consultancy business
19th Mar 20217:00 amRNSStatement regarding Dye & Durham’s withdrawal
18th Mar 20211:11 pmRNSResult of AGM
18th Mar 20218:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
17th Mar 202110:51 amGNWForm 8.3 - IDOX PLC
17th Mar 20217:34 amRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20211:08 pmRNSForm 8.3 Disclosure
16th Mar 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
16th Mar 20219:54 amGNWForm 8.3 - Idox plc
15th Mar 20218:27 amRNSForm 8.5 (EPT/RI) IDOX Plc
15th Mar 20217:00 amRNSTotal Voting Ritghts & Rule 2.9 Announcement
12th Mar 202112:03 pmGNWForm 8.3 - [IDOX plc - 11-03-2021] - (CGWL)
12th Mar 20218:57 amRNSForm 8.5 (EPT/RI) IDOX Plc
12th Mar 20217:00 amRNSDisposal of Idox Compliance
11th Mar 20212:17 pmRNSForm 8.3 Disclosure
11th Mar 202111:38 amGNWForm 8.3 - [IDOX plc - 10-03-2021] - (CGWL)
11th Mar 20218:21 amRNSForm 8.5 (EPT/RI) IDOX Plc
10th Mar 202111:54 amGNWForm 8.3 - [IDOX plc - 09-03-2021] - (CGWL)
10th Mar 20219:46 amRNSForm 8.5 (EPT/RI)
10th Mar 20219:22 amRNSForm 8.5 (EPT/RI) IDOX Plc
9th Mar 202111:44 amGNWForm 8.3 - [IDOX plc - 08-03-2021] - (CGWL)
9th Mar 20218:44 amRNSForm 8.5 (EPT/RI) IDOX Plc
8th Mar 20214:34 pmRNSForm 8.3 - IDOX PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.